首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   518篇
  免费   16篇
  国内免费   15篇
耳鼻咽喉   1篇
儿科学   8篇
妇产科学   8篇
基础医学   54篇
口腔科学   2篇
临床医学   72篇
内科学   126篇
皮肤病学   11篇
神经病学   94篇
特种医学   18篇
外科学   91篇
综合类   3篇
预防医学   33篇
药学   14篇
肿瘤学   14篇
  2023年   5篇
  2022年   7篇
  2021年   25篇
  2020年   11篇
  2019年   9篇
  2018年   18篇
  2017年   14篇
  2016年   14篇
  2015年   17篇
  2014年   27篇
  2013年   28篇
  2012年   44篇
  2011年   45篇
  2010年   25篇
  2009年   31篇
  2008年   40篇
  2007年   41篇
  2006年   39篇
  2005年   17篇
  2004年   23篇
  2003年   22篇
  2002年   28篇
  2001年   3篇
  2000年   2篇
  1999年   3篇
  1998年   1篇
  1997年   1篇
  1994年   1篇
  1991年   2篇
  1989年   1篇
  1988年   1篇
  1987年   1篇
  1986年   2篇
  1983年   1篇
排序方式: 共有549条查询结果,搜索用时 375 毫秒
11.
Summary Antiischemic effects of 1-blocking agents are based on intrinsic negative inotropic and chronotropic properties. Partial 1-agonistic activity, although useful in preserving cardiac function, may counteract such antischemic properties by modulating the intrinsic negative cardiac effects of beta-blockade. To investigate the acute hemodynamic and antiischemic profile of epanolol, a cardioselective 1-antagonist and partial agonist, 20 patients with left coronary artery disease underwent two incremental atrial pacing tests, 45 minutes before (APST I) and 15 minutes after (APST II) 4 mg intravenous epanolol, administered over 5 minutes. Additional measurements were carried out at 1, 3, 5, 10, and 15 minutes after epanolol, at basal and fixed heart rates. Epanolol immediately reduced heart rate with a maximum of 10% at 15 minutes and decreased contractility (Vmax) by 7% (both p<.05), whereas cardiac output fell temporarily by 9% (p<.05). Other hemodynamic parameters did not change, except for a significant 11% reduction in myocardial oxygen demand. Despite comparable pacing conditions, both the double product and contractility decreased significantly less during APST II, resulting in a 17% lower myocardial oxygen consumption (p<.05). Myocardial ischemia was markedly reduced, indicated by normalization of lactate metabolism [lactate extraction 16±7% vs. –7±8% (APST I)], less ST depression (21%), and modulation of LV end-diastolic pressure postpacing (all p<.05 vs. APST I), whereas angina was absent or less in 14 patients. None of the patients reported an adverse effect. Thus, under resting conditions intravenous epanolol induces moderate, short-lasting negative chronotropic and inotropic effects, but does not alter cardiac pump function or vascular resistance, reflecting its additional 1-agonistic properties. Alternatively, during pacing it still reduces ischemia through negative inotropic effects and diminishes myocardial oxygen demand, reflecting its 1-antagonistic profile.  相似文献   
12.
13.
14.
15.
16.
17.
We analyze different aspects of our quantum modeling approach of human concepts and, more specifically, focus on the quantum effects of contextuality, interference, entanglement, and emergence, illustrating how each of them makes its appearance in specific situations of the dynamics of human concepts and their combinations. We point out the relation of our approach, which is based on an ontology of a concept as an entity in a state changing under influence of a context, with the main traditional concept theories, that is, prototype theory, exemplar theory, and theory theory. We ponder about the question why quantum theory performs so well in its modeling of human concepts, and we shed light on this question by analyzing the role of complex amplitudes, showing how they allow to describe interference in the statistics of measurement outcomes, while in the traditional theories statistics of outcomes originates in classical probability weights, without the possibility of interference. The relevance of complex numbers, the appearance of entanglement, and the role of Fock space in explaining contextual emergence, all as unique features of the quantum modeling, are explicitly revealed in this article by analyzing human concepts and their dynamics.  相似文献   
18.
19.
20.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号